Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Adolescents with Juvenile Primary Fibromyalgia Syndrome
NCT01237587Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2011
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of duloxetine in Juvenile Fibromyalgia Syndrome (JFMS), sponsored by Eli Lilly and Company. Started Mar 2011; status: completed.
02
Drugs
duloxetine
03
Conditions
Juvenile Fibromyalgia Syndrome (JFMS)
Beyond the preview
Go deeper on NCT01237587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237587.